Viruses are lean, mean, infection machines. Their genomes are tiny, usually limited to a handful of absolutely essential genes, and they shed extra genomic deadweight extremely fast.
Leo Pharma spending $14M upfront to acquire Timber
Leo Pharma plans to acquire dermatology biotech Timber Pharmaceuticals, which is developing a treatment for a rare, genetic skin disease. The privately held Danish biopharma